IRD insider trading
See Opus Genetics (IRD) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Magrath George | Chief Executive Officer, Director | Sell | Nov 3, 2026 | Nov 5, 2026 | 28,258 | $3.90 | $110.18K | Filing |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | Oct 23, 2026 | Oct 27, 2026 | 4,767 | $3.56 | $16.99K | Filing |
| YERXA BENJAMIN R | President, Director | Sell | Oct 23, 2026 | Oct 27, 2026 | 7,669 | $3.55 | $27.24K | Filing |
| YERXA BENJAMIN R | President, Director | Sell | Oct 23, 2026 | Oct 27, 2026 | 25,520 | $3.53 | $90.13K | Filing |
| Gagnon Robert E. | Chief Financial Officer | Sell | Oct 23, 2026 | Oct 27, 2026 | 14,000 | $3.55 | $49.65K | Filing |
| Magrath George | Chief Executive Officer, Director | Sell | Oct 23, 2026 | Oct 27, 2026 | 9,591 | $3.58 | $34.38K | Filing |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director, See Remarks | Sell | Sep 30, 2026 | Oct 2, 2026 | 556,000 | $4.96 | $2.76M | Filing |
| Gagnon Robert E. | Chief Financial Officer | Sell | Sep 3, 2026 | Sep 8, 2026 | 28,000 | $4.54 | $127.12K | Filing |
| YERXA BENJAMIN R | President, Director | Sell | Jul 23, 2026 | Jul 27, 2026 | 7,429 | $2.97 | $22.06K | Filing |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | Jul 23, 2026 | Jul 27, 2026 | 4,644 | $2.94 | $13.65K | Filing |
| Magrath George | Chief Executive Officer, Director | Sell | Jul 23, 2026 | Jul 27, 2026 | 9,475 | $2.95 | $27.95K | Filing |
| Gagnon Robert E. | Chief Financial Officer | Sell | Jul 23, 2026 | Jul 27, 2026 | 7,783 | $2.95 | $22.96K | Filing |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director, See Remarks | Sell | May 18, 2026 | May 20, 2026 | 1,700,000 | $4.35 | $7.39M | Filing |
| YERXA BENJAMIN R | President, Director | Sell | Apr 23, 2026 | Apr 27, 2026 | 7,470 | $5.24 | $39.12K | Filing |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | Apr 23, 2026 | Apr 27, 2026 | 4,697 | $5.22 | $24.52K | Filing |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | Apr 23, 2026 | Apr 27, 2026 | 1,641 | $5.20 | $8.54K | Filing |
| Magrath George | Chief Executive Officer, Director | Sell | Apr 23, 2026 | Apr 27, 2026 | 9,511 | $5.22 | $49.65K | Filing |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | Apr 23, 2026 | Apr 27, 2026 | 7,542 | $5.19 | $39.16K | Filing |
| Gagnon Robert E. | Chief Financial Officer | Sell | Apr 23, 2026 | Apr 27, 2026 | 7,842 | $5.18 | $40.66K | Filing |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | Mar 16, 2026 | Mar 18, 2026 | 3,719 | $5.25 | $19.53K | Filing |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | Mar 16, 2026 | Mar 18, 2026 | 2,816 | $5.25 | $14.77K | Filing |
| Magrath George | Chief Executive Officer, Director | Sell | Mar 16, 2026 | Mar 18, 2026 | 24,438 | $5.21 | $127.33K | Filing |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | Mar 16, 2026 | Mar 18, 2026 | 3,719 | $5.12 | $19.05K | Filing |
| Gallagher Cam | Director | Buy | Dec 29, 2025 | Dec 31, 2025 | 81,000 | $1.98 | $160.27K | Filing |